
Ana Andreazza
@anacandreazza
Professor of Pharmacology, UofT, CRC in Molecular Pharmacology of Mood Disorder, Thomas C. Zachos Chair Mitochondria Research, Scientific Director of MITO2i
ID: 828709720621989888
http://www.mito2i.ca 06-02-2017 20:59:29
53 Tweet
329 Followers
16 Following





So proud of this excellent review article on evidence for Ketogenic Metabolic Therapy for Serious Mental Illness from two pioneers in #MetabolicPsychiatry Shebani Sethi, MD & Dr. Judith Ford in Journal of Psychiatry & Brain Science. #ketoformentalhealth jpbs.hapres.com/htmls/JPBS_150…


🧵 Today, Milken Institute Strategic Philanthropy and the Baszucki Brain Research Fund announced the first annual #MetabolicMind award recipients. These seven pioneering clinicians are transforming mental health outcomes with Ketogenic Metabolic Therapy. baszuckigroup.com/our-work/metab…

New Huberman Lab Podcast: A DIET FOR MENTAL HEALTH w/Chris Palmer, MD Harvard Medical School • Ketogenic Diet for Depression • Obesity & Mitochondrial Disease • How to Regenerate Mitochondria • Nutrition to Treat Schizophrenia • Ketosis & Fertility, Sleep, Weight hubermanlab.com/dr-chris-palme…

1/4 We are thrilled to honor Iain Campbell, Ph.D. w/ a four-year research fellowship in Metabolic Psychiatry at The University of Edinburgh The University of Edinburgh. He is Co-principal investigator of the first European trial of ketogenic therapies for bipolar disorder. tinyurl.com/55zrpj67













NEWS FLASH: A clinical trial of #KetogenicTherapy for #Bipolar McLean Hospital is now enrolling! A$2M gift from baszuckigroup.org will fund an RCT to assess the impact of a #KetoDiet intervention on metabolism & bipolar symptoms. To enroll, visit bit.ly/3uwmT6B.